Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Document › Details

Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN.

Organisations Organisation Acacia Pharma Ltd.
  Group Acacia Pharma (Group)
  Organisation 2 Euronext Brussels
  Group Euronext (Group)
Products Product Baremsis (APD421)
  Product 2 investment banking
Index term Index term Acacia Pharma–SEVERAL: investment, 201802–201803 initial global offering €40m private placement 11.1m shares at €3.6 + listing on Euronext Brussels
Persons Person Gilbert, Julian C. (Acacia Pharma Ltd 201309 CEO + Co-Founder)
  Person 2 Soden, Christine (Acacia Pharma 201507– CFO joined 201502 before Celltech-Chiroscience + BTG + Optos + Medeva + Oxagen)

Record changed: 2018-03-08


Picture [iito] Made Without Love 650x80px

More documents for Acacia Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px

» top